ArticleEuropean child & adolescent psychiatry2026
Edge-centric brain connectomes reveal two molecularly distinct neurobiological subtypes of adolescent major depressive disorder.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Adolescent major depressive disorder (MDD) is a heterogeneous disorder that complicates diagnosis and treatment. However, the mechanisms underlying this heterogeneity are still unclear. This study investigated the neural and molecular bases of individual differences in adolescent MDD patients by integrating a novel edge-centric brain connectome with transcriptomic and neurotransmitter profiles. Using individualized edge-centric brain functional networks, we computed the nodal entropy for each brain region and identified potential adolescent MDD subtypes via a data-driven clustering algorithm. Machine learning models were constructed to assess whether subtype division could enhance discriminability. Furthermore, connectome‒transcriptome association analysis was performed to investigate the subtype-specific molecular bases underlying nodal entropy changes. We also analyzed the spatial associations between nodal entropy changes and neurotransmitter distributions. This study identified two robust adolescent MDD subtypes: subtype 1 was characterized by lower nodal entropy in the visual and somatomotor networks and significantly greater nodal entropy in the ventral attention, frontoparietal, and default mode networks, whereas subtype 2 showed a contrasting pattern. Subtype-based models significantly improved case‒control discriminability, with the two subtypes characterized by distinct core predictive factors. Nodal entropy patterns of the two subtypes are differentially linked to distinct molecular signatures involving synapse function, development, immune/inflammatory pathways, metabolic/endocrine pathways, and neurochemical modulation profiles. Collectively, our study revealed two adolescent MDD subtypes with distinct neural patterns and specific molecular signaling mechanisms, thereby elucidating the potential mechanisms underlying adolescent MDD heterogeneity.
Indexed as
Identifiers
42640475What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.